Trials / Completed
CompletedNCT03090360
Growth of Infants Fed a New Term Infant Formula
Growth of Infants Fed a New Term Infant Formula With a Prebiotic
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 349 (actual)
- Sponsor
- Société des Produits Nestlé (SPN) · Industry
- Sex
- All
- Age
- 14 Days
- Healthy volunteers
- Accepted
Summary
To evaluate the growth of healthy term infants fed an experimental infant formula with a prebiotic, a commercial control infant formula with a probiotic, but without a prebiotic and human breast milk
Detailed description
Multisite, double-blind, randomized, controlled clinical trial. The purpose of the study is to determine if infants fed a standard infant formula with a prebiotic have a weight gain in line with infants fed a standard starter infant formula without a prebiotic.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIETARY_SUPPLEMENT | Infant formula (CF) | Formula-fed infants will be randomly assigned to receive one of the study formulas (CF or EF) orally, ad libitum, each day from Study Day 1 until Study Day 180, for a treatment duration of approximately 180 days. |
| DIETARY_SUPPLEMENT | Infant Formula (EF) | Formula-fed infants will be randomly assigned to receive one of the study formulas (CF or EF) orally, ad libitum, each day from Study Day 1 until Study Day 180, for a treatment duration of approximately 180 days. |
Timeline
- Start date
- 2017-02-21
- Primary completion
- 2019-04-11
- Completion
- 2019-05-21
- First posted
- 2017-03-24
- Last updated
- 2019-07-05
Locations
7 sites across 2 countries: Belgium, Italy
Source: ClinicalTrials.gov record NCT03090360. Inclusion in this directory is not an endorsement.